Inhibition effect of silencing HPV16 E6 gene on human cervical cancer CaSki cell carcinoma xenograft in nude mice

CHENG Hai-en; ZHANG Yi; ZHANG Cui-li; PAN Wei-wei; SHI Hua; YI Fa-ping; GUO Feng-jin; SONG Fang-zhou

您当前的位置：

首页 >

文章列表页 >

Inhibition effect of silencing HPV16 E6 gene on human cervical cancer CaSki cell carcinoma xenograft in nude mice

更新时间：2025-01-15

- Inhibition effect of silencing HPV16 E6 gene on human cervical cancer CaSki cell carcinoma xenograft in nude mice
- Journal of Army Medical University Vol. 29, Issue 6, Pages: 486-489(2007)
- 作者机构：
  
  重庆医科大学：基础医学院生物化学与分子生物学教研室，公共卫生学院生殖医学系遗传学教研室，临床检验诊断学省部共建教育部重点实验室，重庆市生物化学与分子药理学重点实验室
- 作者简介：
- 基金信息：
- DOI：
  CLC： R73-354;R73-362;R737.33
- Published：2007，
  
  Published Online：30 March 2007，
- 稿件说明：
移动端阅览
CHENG HAI-EN, ZHANG YI, ZHANG CUI-LI, et al. Inhibition effect of silencing HPV16 E6 gene on human cervical cancer CaSki cell carcinoma xenograft in nude mice. [J]. Journal of army medical university, 2007, 29(6): 486-489.
DOI：

CHENG HAI-EN, ZHANG YI, ZHANG CUI-LI, et al. Inhibition effect of silencing HPV16 E6 gene on human cervical cancer CaSki cell carcinoma xenograft in nude mice. [J]. Journal of army medical university, 2007, 29(6): 486-489. DOI：

摘要

目的采用RNA干扰抑制人宫颈癌CaSki细胞裸鼠移植瘤中人乳头瘤病毒（human papillomavirus-16

HPV16）E6基因的表达

观察对裸鼠移植瘤的抑制作用。方法将HPV16 E6 特异性的小干扰RNA（small interference RNA

siRNA）真核表达载体转染到人宫颈癌细胞株CaSki细胞中，经G418筛选，RT-PCR检测E6基因的表达；将细胞接种到BALB/c裸鼠背部皮下，同时将该质粒注射到人宫颈癌CaSki细胞移植瘤的裸鼠中，观察肿瘤出现时间及体积变化；观察肿瘤组织的病理改变。结果成功筛选到持续表达E6 siRNA的CaSki细胞，经RT-PCR检测该细胞中HPV16 E6基因表达降低；裸鼠成瘤实验结果显示

处理后的CaSki细胞成瘤能力明显降低

抑瘤率为71.4%；注射质粒进行基因治疗后，裸鼠肿瘤生长受到抑制，肿瘤的体积与质量明显低于CaSki细胞组，差异具有显著性（

0.05）。病理检查结果显示，经pGensil-CH2处理的肿瘤生长不佳，细胞分裂像少见，组织内有较多坏死区域。结论沉默CaSki细胞中HPV16 E6基因的表达能明显降低宫癌细胞的成瘤作用。

Abstract

Objective To learn the effect on carcinoma xenograft in nude mice by inhibiting human papillomavirus 16(HPV16) E6 gene expression in CaSki cell. Methods The recombinant plasmids expressing HPV16 E6 small interference RNA (siRNA) were transfected into CaSki cell. The cells expressing recombinant plasmid was screened out with G418. The expression of E6 mRNA was determined by RT-PCR. The cells were inoculated into BALB/c nude mice subcutaneouly and the growth of the xenograft carcinoma was observed. After the pGensil-CH2 recombinant was injected into the carcinoma

the growth of carcinoma and pathological changes of carcinoma were observed. Results The CaSki cell expressing E6 siRNA was obtained

and HPV16 E6 mRNA expression in CaSki cell was down-regulated. The oncogenicity of the CaSki cell expressing E6 siRNA was degraded

the inhibition rate was up to 71.4% as compared with that of control group. The growth of tumor in nude mice was inhibited after the E6 siRNA plasmids were injected into the nude mice. The volume and weight of the tumor treated by siRNA were smaller than that of control group significantly. More necrotic area and less cell division phase were observed under light microscope in the E6 siRNA treated tumor. Conclusion The oncogenicity of the CaSki cell was degraded after silencing HPV16 E6 gene in CaSki cell by E6 siRNA.

关键词

宫颈肿瘤RNA干扰HPV16E6基因

Keywords

cervical cancerRNA interferencehuman papillomavirus 16E6 gene

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Effect of targeted Sox2 silencing on expression of β-catenin and TIF1γ in human breast cancer MDA-MB-231 cells

Effect of LncRNA LOC100506123 on proliferation and migration in pancreatic cancer cells

Vitamin E-coupled nanoparticles-delivered siRNA inhibits expression of hepatitis C virus core protein in vitro

Related Author

Bai Lu

Zhou Jianrong

Wang Zhijuan

Liu Zhou

Liu Juanjuan

Dong Wei

Qi Mengchun

Feng Xiaojie

Related Institution

Department of Otorhinolaryngology, the First Affiliated Hospital of Chongqing Medical University

Department of Oral and Maxillofacial Surgery, School of Stomatology, Department of Pathology, College of Basic Medicine, North China University of Science and Technology

Department of Pathology, Research Center for Molecular Medicine and Cancer, Chongqing Medical University

Institute of Hepatobiliary Surgery, Southwest Hospital, Institute of Immunology, College of Basic Medical Sciences, Third Military Medical University

Department of Scientific Research Affairs, Department of Laboratory Medicine, Department of Infectious Diseases, the Second Affiliated Hospital of Chongqing Medical University

⁰